Export

EN
FR
Betamethasone
Essential medicine status
Section:
13. Dermatological medicines 13.3. Dermatological medicines > Anti-inflammatory and antipruritic medicines
ATC codes: D07AC01
EMLc
Indication
Dermatitis or eczema ICD11 code: EA8Z
INN
Betamethasone
Medicine type
Chemical agent
List type
Core (EML)
(EMLc)
Formulations
Local > Topical > Cream: 0.1% (as valerate)
Local > Topical > Ointment: 0.1% (as valerate)
EML status history
First added in 1977 (TRS 615)
Changed in 1979 (TRS 641)
Changed in 2007 (TRS 950)
Changed in 2021 (TRS 1035)
Sex
All
Age
Also recommended for children
Age restriction
Hydrocortisone preferred in neonates.
Therapeutic alternatives
Medicines within the same pharmacological class can be used
Therapeutic alternatives limitations
Therapeutic alternatives are medicines in the 4th level ATC chemical subgroup:D07AC Corticosteroids, potent (group III).
Therapeutic alternatives limitations for EMLc
Therapeutic alternatives are medicines in the 4th level ATC chemical subgroup:D07AC Corticosteroids, potent (group III).
Patent information
Patents have expired in most jurisdictions
Wikipedia
Betamethasone
DrugBank
Betamethasone
Summary of evidence and Expert Committee recommendations
Following the review of square box listings on the EML and EMLc, the Expert Committee recommended that medicines in 4th level ATC chemical subgroup, D07AC Corticosteroids, potent (group III), be specified as therapeutic alternatives under the square box listing for betamethasone on the EML and EMLc.